Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Medivation's Xtandi sales fell short in Q1, but analysts say it's gaining on J&J's Zytiga
Medivation's Xtandi sales fell short in Q1, but analysts say it's gaining on J&J's Zytiga
Medivation's Xtandi sales fell short in Q1, but analysts say it's gaining on J&J's Zytiga
Submitted by
admin
on May 20, 2015 - 6:15pm
Source:
Fierce Pharma Marketing
News Tags:
Medivation
Xtandi
Astellas
JNJ
Zytiga
Headline:
Medivation's Xtandi sales fell short in Q1, but analysts say it's gaining on J&J's Zytiga
Do Not Allow Advertisers to Use My Personal information